AKT1 and melanoma: Several mechanisms can activate PI3K/AKT/mTOR signaling in melanoma, including the loss of tumor suppressor PTEN functions, mutations in AKT and PIK3CA, and compensatory signaling through growth factor receptors (19, 42, 43).